StartUp Health January 20, 2026
From AI-driven drug discovery and precision diagnostics to autism care, neuromodulation, and clinical workflow automation, this week’s global funding underscores how data-driven approaches are reshaping health innovation across multiple markets and care settings.
This week’s reported global health innovation funding included:
Precede Biosciences, a Boston, MA-based precision diagnostics and data company focused on enabling the next generation of precision medicines, raised $83.5M from Labcorp Venture Fund, UPMC Enterprises, Mirae Asset Capital Life Science, Mirae Asset Capital, 28 Capital, Alexandria Venture Investments, Illumina Ventures, 5AM Ventures, Bristol Myers Squibb, Osage University Partners, Binney Street Capital, and Lilly Asia Ventures. <source>
Proxima (fka VantAI), a Boston, MA- and New York, NY-based AI-native biotech company focused on AI-driven drug discovery for proximity therapeutics...
Today's Sponsors
Today's Sponsor